Comparative zymographic analysis of metallopeptidase of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis isolates from Peru
- PMID: 22562004
- DOI: 10.1016/j.parint.2012.03.007
Comparative zymographic analysis of metallopeptidase of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis isolates from Peru
Abstract
American tegumentary leishmaniasis (ATL) in Peru is mainly associated with Leishmania (Viannia) peruviana and L. (V.) braziliensis. These parasites are genetically related, and their characterization as distinct species is controversial. Despite their genetic similarity, each species is associated with different clinical manifestations of ATL; L. (V.) peruviana causes only cutaneous leishmaniasis, whereas L. (V.) braziliensis can cause both cutaneous and mucocutaneous leishmaniasis. Because the primary cutaneous lesions caused by infection with these species are indistinguishable, it is necessary to develop a suitable method to differentiate them in order to prevent possible metastasis to oropharyngeal mucosa. In the present study, we investigated the proteolytic profile of L. (V.) peruviana and L. (V.) braziliensis isolates from Peru by zymographic analysis in SDS-PAGE copolymerized with gelatin. Enzymes were characterized according to their pH range of activity and sensitivity to distinct peptidase inhibitors. We observed that L. (V.) peruviana isolates displayed three proteolytic bands with molecular masses ranging from 55 to 80 kDa, whereas L. (V.) braziliensis isolates showed six proteolytic activities between 55 and 130 kDa. Using specific inhibitors, we determined that these proteolytic activities are due to metallopeptidases and present optimal activity between the pH range 5.5 and 10.0. Our results suggest that the expression of metallopeptidases in L. (V.) peruviana and L. (V.) braziliensis isolates from Peru is species-specific.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.J Infect Dis. 2007 Jun 15;195(12):1846-51. doi: 10.1086/518041. Epub 2007 May 3. J Infect Dis. 2007. PMID: 17492601
-
Development of a genetic assay to distinguish between Leishmania viannia species on the basis of isoenzyme differences.Clin Infect Dis. 2006 Mar 15;42(6):801-9. doi: 10.1086/500326. Epub 2006 Feb 10. Clin Infect Dis. 2006. PMID: 16477557
-
Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana.Parasitology. 2008 Mar;135(3):319-26. doi: 10.1017/S0031182007003848. Epub 2007 Oct 26. Parasitology. 2008. PMID: 17961284
-
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x. Parasite Immunol. 2009. PMID: 19646206 Review.
-
Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador: the causative Leishmania parasites and clinico-epidemiological features.Acta Trop. 2018 Jan;177:135-145. doi: 10.1016/j.actatropica.2017.09.028. Epub 2017 Oct 7. Acta Trop. 2018. PMID: 29017878 Review.
Cited by
-
Descriptive and molecular epidemiology of leishmaniasis diagnosed from clinical samples in the United States, 2021-2022.Microbiol Spectr. 2024 Oct 3;12(10):e0105524. doi: 10.1128/spectrum.01055-24. Epub 2024 Sep 9. Microbiol Spectr. 2024. PMID: 39248481 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources